drugset / Trial / NCT00550303
Study Comparing Formulations of Bazedoxifene/Conjugated Estrogens
Non-randomizedCrossoverOpen-labelTreatment
Summary
The primary purpose is to determine bioavailability of Bazedoxifene/conjugated estrogen formulations for future testing purposes.
Timeline
- Start
- 2007-10
- Primary completion
- —
- Completion
- 2007-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bazedoxifene | Other / unclassified | — | — |
| Subject | conjugated estrogens | Other / unclassified | — | — |
Indications
No indication recorded.